Browsing by Author "Ulamec, Monika"

Now showing items 1-2 of 2

The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status.

Gatalica, Zoran; Kuzmova, Nataliya; Rose, Inga; Ulamec, Monika; Peric Balja, Melita; Skenderi, Faruk; Vranić, Semir... more authors ... less authors ( Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina , 2023 , Article)
In the current study, we assessed the prevalence and molecular features of HER2-low phenotype in the apocrine carcinomas of the breast (ApoCa) and its relationship with tumor-infiltrating lymphocytes (TILs). A cohort of ...
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer

Kheraldine, Hadeel; Hassan, Arij Fouzat; Saeed, Sumayyah; Merhi, Maysaloun; Mateo, Jericha Miles; Ulamec, Monika; Peric-Balja, Melita; Vranic, Semir; Al-Thawadi, Hamda; Moustafa, Ala-Eddin Al... more authors ... less authors ( Elsevier , 2025 , Article)
BackgroundHER2-positive breast cancer (BC) is highly aggressive with a poor prognosis. It is driven by HER2 oncoprotein activation/crosstalk with other receptors like EGFR/(HER1), HER3, and HER4, in addition to IGF-1R, ...